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ABSTRACT 
Objectives: The present study was aimed to evaluate the magnitude of oxidative stress and levels of enzymatic antioxidants in Oral Squamous cell 
carcinoma (OSCC) patients receiving radiotherapy (RT) and chemo radiotherapy (CRT). Venous blood samples were collected from 20 healthy 
subjects, 20 disease control patients (without treatment), 20 oral cancer patients who received chemo radiotherapy and 20 oral cancer patients 
receiving radiotherapy and were analyzed for antioxidant status using various assay techniques. 
Methods: The present study measured the levels of three antioxidants enzymes: Superoxide dismutase (SOD), Glutathione Peroxidase (GPX
Results: The plasma levels of antioxidant enzymes (SOD, CAT, and GP
), 
Catalase (CAT) in the plasma samples of 20 patients who were proven with biopsy-Squamous cell carcinoma of the oral cancer with clinical stage 
III/IV and were receiving radio and chemo radiotherapy. Same enzymes were also estimated in 20 healthy individuals and disease control patients 
(who were admitted in to the cancer clinic). 
X
Conclusion: This present study also showed decreased levels of antioxidant enzymes in the plasma of the oral cavity cancer patients after radiation 
therapy as compared to the chemoradiotherapy receiving oral cancer patients. An appreciable progress in antioxidant levels were observed in 
patients after receiving chemoradiotherapy (CRT) and observed to be more effective than after radiotherapy (RT). The reason for this observation 
was believed that concomitant chemoradiation and radiotherapy caused a reduction in the lipid peroxidation process and an improvement in the 
antioxidant levels of the oral cancer patients. But the radiation therapy produces high oxidative stress when compared to chemoradiotherapy in 
Oral Squamous Cell Carcinoma. 
) were lower in the oral cancer patients as compared to those in the healthy 
individuals. Superoxide dismutase levels in healthy control patients were found to be 190.4µg/dl, 34.54 µg/dl in disease control patients, 46.16 
µg/dl in radiotherapy received group patients and 81.48 µg/dl in chemo and radiotherapy received group patients. Glutathione peroxidase levels 
were found to be 65.713 µg/dl in healthy control group patients, 13.8 µg/dl in disease control patients, 16.49 µg/dl in radiotherapy received group 
patients, 34.2 µg/dl in chemo and radiotherapy received group patients. Catalase enzyme levels were found to be 52.37 µg/dl in healthy control 
group patients, 12.35 µg/dl in disease control group patients, 22.34 µg/dl in radiotherapy received group patients, 27.18 µg/dl inchemo and 
radiotherapy received group patients. These enzymes also showed significant changes with radiotherapy and chemoradiotherapy. Antioxidant 
enzymes in the plasma of the oral cancer patients after radiation therapy lowered as compared to the plasma levels of enzymes after 
chemoradiotherapy.  
Keywords: Oral Cancerr, Oxidative stress, Antioxidant enzymes, Chemo and radiotherapy, Superoxide dismutase, Glutathione Peroxidase, Catalase. 
 
INTRODUCTION 
Oral cancer is an important type of cancer among all cancers globally 
and is one of the six most commonly occurring malignant disorders 
in the south-east Asian population [1]. Tobacco chewing is the major 
etiological factor in its development. Other factors include alcohol, 
genetic factors and diet lacking in micronutrients and vitamins. 
Tobacco contains large amounts of pro-oxidants that can directly 
initiate the process of lipid peroxidation which is a chain reaction 
process producing a continuous production of free radicals which 
lead to cellular damage [1]. 
Reactive oxygen species (ROS) such as superoxide radicals, hydroxyl 
radicals, hydrogen peroxide and free radicals play an important role 
in cancer development. ROS are uncharged molecules containing at 
least one unpaired electron (or) reactive non radical compounds 
capable of oxidizing biomolecules. These free radicals and other ROS 
are called pro-oxidants [2,3]. ROS can cause DNA base alterations, 
standard DNA breaks damage to tumor suppressor gene and 
activates the expression of proto-oncogenes [3]. 
An imbalance between the production of pro-oxidants (ROS) and 
antioxidants capacity creates oxidative stress [4]. Antioxidants are 
the most important substances of defense against free radicals 
damage and are essential for the oxidative damage reduction 
maintaining health and quality of life. Antioxidant enzymes are 
mainly involved in the decomposition of ROS. In general, there are 
two types of antioxidants: Enzymatic and Non-enzymatic 
antioxidants. These enzymes protect the cell against oxidative 
injury. Superoxide dismutase (SOD), Glutathione Peroxidase (GPX
The typical mode of treatment for early stage oral cancer is chemo 
radiotherapy (CRT) and radiotherapy (RT) were as advanced oral 
cancer is resected by surgery followed by external beam 
radiotherapy. The most common type of treatment is radiotherapy 
for oral cancer patients. External beam radiation and gamma 
radiation which is a potential source of field cancerization of the 
upper aero-digestive tract for radiotherapy are available, but the 
most commonly used isotopes are Iridium-192 and Iodine-125 [6,7]. 
), 
and Catalase (CAT) are the first line enzymatic antioxidant defense 
systems responsible for scavenging free radicals. Non-enzymatic 
antioxidants are Vitamin C, E, A, Selenium inhibit both initiation and 
promotion of carcinogenesis [5]. 
Chemotherapy can be administered as adjuvant treatment, as a 
follow-up treatment after the primary treatment. The patient may 
develop toxicity of concurrent therapy, as radiation therapy and 
chemotherapeutic agents may possibly interact with one another. 
The classic foundation of the chemotherapy/radiation interaction 
includes spatial interaction, radiation sensitization, and toxicity 
independence. Spatial interactionrecognizes that radiation therapy 
will work loc oregionally (i.e., within the irradiated field), while 
chemotherapy will work systematically. While this definition allows 
for some chemotherapyantitumor activity within the radiated field, 
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the major goal forchemotherapy is to eradicate systemic 
micrometastases [8]. 
The mechanism of the action of radio and chemotherapeutic agents 
is to alter cellular homeostasis, thus modifying the signal 
transduction pathways and predisposing to apoptosis [9]. Some of 
the studies have demonstrated that increased oxidative stress after 
radio and chemotherapy while others have reported decreased 
oxidative stress after chemoradiotherapy concomitantly[10]. 
The main aim of this study was to evaluate the levels of the 
enzymatic antioxidants in patients with oral squamous cell 
carcinoma before and after treatment. Antioxidant levels SOD, GPX 
and CAT were evaluated in plasma of patients with oral cancer, in 
healthy individuals and in post therapy individuals to know whether 
chemoradiotherapy or radiation therapy is responsible for the ROS 
formation, depletion of antioxidants and development of oxidative 
stress. The antioxidants detection can be used as a marker in future 
therapeutic strategy for oral cancer. 
This study was taken up with a view of the Indian studies on the 
effects of radiation therapy and chemo radiotherapy on oxidant-
antioxidant status in oral squamous cell carcinoma (OSCC) and to 
investigate and compare the enzymatic antioxidant alterations in the 
plasma of oral Squamous cell carcinoma patients receiving chemo 
radiotherapy (CRT), radiotherapy (RT) receiving patients and 
healthy individuals. 
MATERIALS AND METHODS 
Materials 
Sample distribution  
This comparative study was conducted on 80 patients with biopsy 
proven Oral Squamous Cell Carcinoma (OSCC) of the oral cavity, 
registered at the oral cavity cancer department, in various Cancer 
clinics atWarangal,Telangana,India. 
Out of 80 patients, 20 patients of OSCC received radiotherapy (RT), 
20 patients of OSCC received chemo radiotherapy (CRT) and 20 
were healthy individuals(Control), 20 were disease control patients. 
The individuals were categorized into 4 groups:  
Group-I: Twenty disease control group (without any treatment) who 
visited the department of oral cancer medicine and radiology. 
Among these patients 13 were males and 7 were females with the 
age range from (18-70) having OSCC.  
Group-II: Twenty patients who were receiving radiotherapy. Among 
these patients 13 were males and 7 were females with the age range 
from (18-70)having OSCC. 
Group-III: Twenty patients who were receiving chemo radiotherapy 
after the completion of radiotherapy. Among these patients 17 were 
males and 3 were females with the age range from (18-70) having OSCC. 
Group-IV: The control group comprises 20 healthy individuals. Informed 





• Patients with an age range from 18-70 years. 
• Patients who came to oncology department clinically diagnosed 
with OSCC. 
• Patients who are not on any treatment for OSCC 
• Patients who have agreed for the biopsy attended the clinic 
• Patients who were receiving Concomitantchemo radiotherapy 
(CRT). 
• Patients who were receiving radiotherapy (RT) 
• Normal subjects without any oral lesions and systemic diseases. 
Exclusion criteria 
• Patients below the age 18 years and above 70 years. 
• Patients with any systemic diseases like diabetes mellitus, 
cardiovascular diseases, renal dysfunction, liver disorders. 
• Patients with other type of oral cavity cancers like oral sub 
mucous fibrosis and Oral leukoplakia. 
• Pregnancy 
Methods 
Source of data 
The study was carried out at St. Ann’s Cancer Hospital, Warangal, 
Telangana,India. The study protocol was approved by the Ethical 
Committee ofKakatiya Medical College,Telangana, India. All subjects 
were interviewed before clinically examined in the 
oncologydepartment and relevant demographics data were 
collected. Informed consent was obtained from the patients. All the 
study group patients i. e. OSCC group patients were regular tobacco 
chewers (about 5-8years) and alcoholics. 
Collection of samples 
Aseptic precautions were taken during collection of blood samples. 
Approximately 5 ml of over night fasting venous blood samples were 
collected from the antecubital vein using sterile syringe from each 
individual in all groups and collected in 5 ml vials. Plasma was 
separated by using EDTA as an anticoagulant and blood sample was 
centrifuged at 3000rpm for 15 min. Then separated plasma was 




Superoxide dismutase (SOD) assay  
Superoxide dismutase assay is based on the inhibition of 
superoxideinduced NADH oxidation. Decrease in the rate of NADH 
oxidation is dependent on the enzyme concentration, and saturation 
levels were attainable by recording the corresponding readings, 
spectrophotometrically at 520 nm [11]. 
Glutathione Peroxidase (GPx)assay 
Estimation of Glutathione Peroxidaseactivitywas measured by using 
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hydrogen peroxide and the rate of disappearance 
ofNADPHat37°Candwasrecordedspectrophotometricallyat 340 nm [11]. 
Catalase (CAT) assay 
CAT was assayed by colorimetric method. The colour produced by 
the reaction of H2O2 with dichromate in acetic acid was measured at 
620 nm [11]. 
Statistical analysis  
The quantified variables in the study (age, sex, superoxide dismutase 
(SOD), glutathione Peroxidase (GPx)and CAT levels) were subjected 
to statistical analysis. All these values were presented as mean ± 
standard deviation. The data were statistically analyzed using Graph 
pad prism 
 
statistical software. Unpaired Student′ s ′t′ test was 
performed to compare the levels between control and study groups. 
P value less than 0.05 was considered significant.  
RESULTS 
Demographics  
All afore mentioned groups consisted of (80%) males and a (20%) 
female, their distribution demographics is shown in figure 1. 
Fig. 1: Distribution of OSCC patients based on treatment pattern 
 
Figure 2 illustrates the comparison of mean GPx levels in between 
healthy control group, disease control group, radiation (RT) 
received and CRT received group. In chemo and radiotherapy (CRT) 
received group the GPx level was increased significantly (p<0.001) 
compared to disease control and RT group. 
 
Table 1: Distribution of OSCC patients into age groups 
Age OSCC with CT 
(n=20) (%) 






























 As shown in table 1, the age of the individuals at diagnosis of cancer ranged between 18-70 years with mean age of 44 years. More than half of the 
OSCC patients were diagnosed between the ages of 25-50 years. 4 were aged younger than 30 years and 16 were aged older than 60 years at 
presentation. 
 
Table 2: Distribution of risk factors among OSCC patients 
Risk factors Chemotherapy receiving OSCC Radiotherapy receiving OSCC Total (%) Odds ratio 
Tobacco chewing, Smoking 7 4 11 (27%) 1.75 
Alcohol 0 0 0 (0%) 0 
(Paan), Betel quid 4 6 10 (25%) 0.6 
Both alcohol and tobacco 9 10 19 (47%) 0.9 
As shown in table 2, among 40 patients with OSCC attended the clinic, 19 patients were on both alcohol and tobacco, 11 patients were habituated to 
tobacco chewing and smoking and 10 patients were on chyni (Paan), betel quid.  
 
 
Fig. 2: Comparison of GPx levels in RT and Chemo and 
radiotherapy (CRT) with oral cancer. 
 
Figure 3 shows the comparison of mean SOD levels in between 
healthy control group,disease control group, radiation (RT) received 
group and CRT received group. In chemo and radiotherapy (CRT) 
received group the GPx level was increased significantly (p<0.001) 
compared to disease control and RT group.  
 
Fig, 3: Comparison of SOD levels in RT and Chemo and 
radiotherapy (CRT) with oral cancer 
 
Figure 4 shows the comparison of mean CAT levels in between 
healthy control group,disease control group, radiation (RT) received 
group and CRT received group. In chemo and radiotherapy (CRT) 
received group the GPx level was increased significantly (p<0.001) 
compared to disease control and RT group.  
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Fig. 4: Comparison of CAT levels in RT and Chemo and 
radiotherapy (CRT) with oral cancer 
 
A statistically significant difference was observed (p<0.001) with 
higher mean GPx, SOD and CAT values in CRT and RT (post 
treatment) received the group in comparison with the disease 
control group (pre treatment). Thus, disease control group showed 
the lowest mean GPx, SOD, CAT levels when compared with healthy 
individuals and post treatment (CRT & RT) received group. 
DISCUSSION 
Oral cancer appears to be one of the major causes of mystery and death. 
Radiotherapy is one of the clinical means by which oral cancer can be 
treated [12]. Oxidative stress is a mismatch between the production of 
damaging ROS and the efficacy of the antioxidant defense. In oxidative 
stress there is an excessive production of ROS and there is a significant 
decrease or lack of antioxidant enzymes defense [12]. 
This study was mainly involved in evaluating and comparing the 
antioxidant status in between disease control group and oral cancer 
patients receiving chemo radiotherapy (CRT) and radiotherapy (RT). A 
majority of oral cancer patients were 80% males and 20% females who 
had tobacco, betel quid chewing and alcohol consumption. Previous 
studies have shown that these habits have carcinogenic effects [13]. 
Antioxidant enzymes such as SOD,GPx and CAT can directly 
counterbalance the oxidant attack and protect the cells against DNA 
damage. The plasma levels of enzymatic antioxidants (SOD, GPx and 
CAT) were lower in the disease control group as compared to those 
in the healthy subjects [11]. 
Chemo and radiotherapy can be used for the treatment of oral 
cancer. But the treatment is used to destruct the ROS and against 
antioxidant defense system. As it is well known that enzymatic 
antioxidant (SOD, CAT and GPx) levels increases when patients 
received chemo radiotherapy or radiotherapy for a long while, but the 
progress in the antioxidant levels at very initial stages of the therapies 
were never determined [14]. So, this study showed that the 
percentage increases of antioxidant levels in receiving both kinds of 
therapies were determined and the summary of the study is as follows 
SOD 
The optimum levels of SOD are 164-240µg/dL[11]. Recent studies 
on SOD revealed that deficiency of SOD levels leads to abnormalities 
like ocular disturbances, anemia [12]. In disease control patients the 
concentration of SOD levels were found to be below the optimum 
levels. A study of these patients case sheets gave an impression that 
these patients were suffering from anemia grade I-II and visual 
disturbances[11,13] and also the same individuals showed an 
appreciable increase in SOD levels after chemo radiotherapy (CRT) 
[13]. Progress in SOD levels afterchemoradiotherapy and 
radiotherapy revealed that the chemoradiotherapy is more effective 
treatment than radiotherapy which was in concordance with the 
study by Sun Y, Oberley LW. 
GPx 
The optimum levels of GPx are 27.5-73.6µg/dL [14].Recent studies 
on GPx revealed that deficiency of GPx levels leads to liver damage 
[15,16]. In disease control patients the concentration of GPx levels 
were found to be below the optimum levels. Study of these patients 
case sheets gave an impression that the bilirubin (direct, indirect 
and total) levels of these patients were found to be increased [16]. 
Where the same patients showed that there was an appreciable 
increase in GPx levels after chemoradiotherapythan after only 
radiotherapy. The percentage of progress in GPx levels after 
chemoradiotherapy indicated that the chemoradiotherapy (CRT) is 
more effective treatment than radiotherapy (RT) which was in 
concordance with the study by Sun Y, Oberley LW. 
CAT 
The optimum levels of CAT are 50-60µg/dL[17]. Recent studies on 
CAT revealed that deficiency of CAT levels leads to abnormalities 
like respiratory diseases (runny nose, bronchial infections and 
cough) and gastrointestinal disorders [15,16,17]. 
The low activities of these antioxidant enzymes play an important 
role in progression of lesion and leads to the development of 
oxidative stress [15]. This suggests that lower antioxidant enzymes 
activity in oral cancer patients might be due to the depletion of the 
antioxidant defense system.[18]Some of the studies demonstrated 
that the adjuvant oral administration of antioxidant 
supplementation during conventional oral cancer treatment is still a 
matter of controversy; because the mechanisms of chemo 
radiotherapy (CRT) and radiotherapy (RT) are based in part on the 
production of free radicals. [19,20]Previous studies have shown that 
antioxidants can inhibit neoplastic cell growth by complex 
mechanisms whereas,[21]. Disease control patients were observed 
to suffer from respiratory diseases, GIT disturbances, anemia and 
other co-morbidity conditions before treatment. After the treatment, 
all these abnormalities frequency were reduced. Thus, this conveys 
that decreased antioxidants (SOD, GPx and CAT) levels may also 
result in hematological, respiratory and liver damage. Thus the 
relationship between them is inversely proportional [21,22]. 
In disease control 
patients the concentration of CAT levels were found to be below the 
optimum levels. Study on these patients case sheets gave an 
impression that these patients were suffering from pneumonia, 
dysphasia (difficulty in swallowing) and digestive problems [17]. 
Same patients showed that there was an appreciable increase in CAT 
levels after chemoradiotherapy and radiotherapy. But this study 
indicated that there was an appreciable increase in CAT levels after 
chemoradiotherapy than after only radiotherapy which was in 
concordance with the study by Greenwald R A. 
Some studies have also shown that antioxidants given under 
controlled circumstances are able to increase the therapeutic 
efficacy of chemo and radiotherapy by improving tolerance and the 
sensitivity of the tumor while diminishing the toxic effects on 
healthy cell system[21]. Therapeutic effect was better in the group 
of patients received the antioxidant combination in addition to 
chemo and radiotherapy than in the group those patients were 
treated with radio and chemotherapy alone [23]. 
CONCLUSION 
A comparative study of enzymatic antioxidant levels like SOD, GPx 
and CAT in patients after receiving radiation therapy and concurrent 
chemoradiotherapy regimen represents the best current standard 
therapy option for many patients with regionally advanced solid 
tumors, and improves the probability of cure. An appreciable 
progress in antioxidant levels was observed in patients after 
receiving chemoradiotherapy observed to be more effective than 
after radiotherapy. Chemotherapy given with RT leads to improved 
outcome versus RT alone. 
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ABBREVIATIONS 
OSCC –Oral Squamous Cell Carcinoma, CRT –Chemoradiotherapy 
RT – Radiotherapy, SOD –Superoxide dismutase 
GPx –Glutathione Peroxidase, CAT –Catalase 
ROS –Reactive Oxygen Species, µg/dL –Microgram per deciliter
 
 
